Meta-analysis of Shugan Jieyu Capsule for depression in patients with coronary heart disease

INTRODUCTION: Shugan Jieyu Capsule (SGJYC) has been prescribed to treat primary and secondary depression; however, whether it can benefit depression of patients with coronary heart disease (CHD) remains controversial. This meta-analysis aimed to evaluate the efficacy and safety of SGJYC in treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhen, Gu, Chunhua, Lei, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470748/
https://www.ncbi.nlm.nih.gov/pubmed/37653746
http://dx.doi.org/10.1097/MD.0000000000034685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470748/
https://www.ncbi.nlm.nih.gov/pubmed/37653746
http://dx.doi.org/10.1097/MD.0000000000034685

Ejemplares similares